The effect of four flower herbal vaginal gel and auricular therapy on atrophic vaginitis

The effect of four flowers herbal vaginal gel and auriculotherapy in comparison with placebo on atrophic vaginitis in women referred to selected medical centers affiliated to Isfahan University of Medical Sciences in 2021

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20211013052757N1

Enrollment

Registered

2022-02-11

Start date

2021-12-22

Completion date

Unknown

Last updated

2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Volvovaginal atrophy. Postmenopausal atrophic vaginitis

Interventions

Intervention 1: First intervention group: In the herbal vaginal gel group, in the first session after completing the forms, 4 tubes of vaginal gel in 30 gram tubes are delivered to the patient for c

Eligibility

Sex/Gender

Female

Age

45 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age: 45 to 65 years old 12 months have passed since menopause Symptoms of vaginal atrophy Patient consent to participate in the project Being married Natural Pap smear in the past year

Exclusion criteria

Exclusion criteria: Breast or uterine cancer Abnormal vaginal bleeding Vaginal device abnormalities Taking oral hormonal medication 8 weeks before treatment Use of topical hormonal creams or topical lubricants in the last month

Design outcomes

Primary

Measure	Time frame
Volvaginal Atrophy Mental Symptoms. Timepoint: Completion of Volvaginal Atrophy Mental Symptoms Questionnaire before intervention, end of week 4 and end of week 8 after intervention. Method of measurement: Volvaginal Atrophy Mental Symptoms Questionnaire.;Women's sexual function index. Timepoint: Completion of women's sexual function index questionnaire before the intervention, end of week 4 and end of week 8 after the intervention. Method of measurement: Women's sexual function index questionnaire.;Quality of life for postmenopausal women. Timepoint: Completion of quality of life evaluation questionnaire for postmenopausal women before the intervention, end of week 4 and end of week 8 after the intervention. Method of measurement: Quality of life evaluation questionnaire for postmenopausal women.	—

Measure

Time frame

Volvaginal Atrophy Mental Symptoms. Timepoint: Completion of Volvaginal Atrophy Mental Symptoms Questionnaire before intervention, end of week 4 and end of week 8 after intervention. Method of measurement: Volvaginal Atrophy Mental Symptoms Questionnaire.;Women's sexual function index. Timepoint: Completion of women's sexual function index questionnaire before the intervention, end of week 4 and end of week 8 after the intervention. Method of measurement: Women's sexual function index questionnaire.;Quality of life for postmenopausal women. Timepoint: Completion of quality of life evaluation questionnaire for postmenopausal women before the intervention, end of week 4 and end of week 8 after the intervention. Method of measurement: Quality of life evaluation questionnaire for postmenopausal women.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElahe Naderiafshar

Esfahan University of Medical Sciences

e.naderiafshar@resident.mui.ac.ir+98 31 3792 8155

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026